Familial Mediterranean fever in the colchicine era: the fate of one family.
In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of familial Mediterranean fever (FMF), a family is presented with 6 out of 9 siblings affected by FMF. Each patient represents a different stage of the amyloidotic kidney disease of FMF and the effect of continuous colchicine treatment on its course. Considered together, the members of this family present an almost complete clinical, genetic, and behavioral picture of the disease.
Zemer
D
D
Heller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer, Tel-Aviv University Medical School, Israel.
Livneh
A
A
Pras
M
M
Sohar
E
E
D000328:Adult; D000686:Amyloidosis / Q000235:genetics / Q000517:prevention & control / Q000601:surgery; D003078:Colchicine / Q000008:administration & dosage / Q000627:therapeutic use*; D010505:Familial Mediterranean Fever / Q000188:drug therapy* / Q000235:genetics*; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000235:genetics / Q000517:prevention & control / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D010375:Pedigree; D010641:Phenotype; D011247:Pregnancy
D003078:Colchicine